Target intelligence / Profile preview

Myotubularin-related protein 13 (SBF2)

Target
SBF2
Molecular classification
Pseudophosphatase, Myotubularin family, DENN/MADD domain-containing protein
01

Overview

Myotubularin-related protein 13 (SBF2) is a pseudophosphatase in the myotubularin family encoded by the SBF2 gene in humans. It plays an essential role in cellular signaling, particularly in the maintenance of the myelin sheath surrounding neurons, and in the development of ocular trabecular meshwork. SBF2 acts as a guanine nucleotide exchange factor (GEF) for Rab GTPases. Unlike its active phosphatase relatives, it lacks catalytic activity but is involved in complex protein-protein interactions. Mutations or deficits in SBF2 function result in a demyelinating neuropathy known as Charcot-Marie-Tooth disease type 4B2, manifesting as abnormal myelin structure, and may cause glaucoma when protein function is completely lost. SBF2 gene variants have also been associated with increased susceptibility to taxane-induced peripheral neuropathy in cancer patients[1][2][4][5][7].

Other names
SET binding factor 2CMT4B2KIAA1766MTMR13DENND7BInactive phosphatidylinositol 3-phosphatase 13
02

Biological functions

Cellular signalingMyelin formation and maintenanceActivation of Rab GTPases (Guanine nucleotide exchange factor activity)Trabecular meshwork development in the eye
03

Disease associations

Peripheral neuropathy (Charcot-Marie-Tooth disease type 4B2)Glaucoma (with complete loss of function)Increased risk of taxane-induced peripheral neuropathy
04

Safety considerations

Loss of function may lead to demyelinating neuropathy (CMT4B2) and glaucoma
05

Biomarkers

SBF2 mutation (for risk of Charcot-Marie-Tooth disease type 4B2 and possibly glaucoma)Rare SBF2 variants (for risk of taxane-induced peripheral neuropathy in cancer therapy)

Beyond the preview

Go deeper on Myotubularin-related protein 13 (SBF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myotubularin-related protein 13 (SBF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call